Xerofung 100 Capsule contains Itraconazole 100 mg, a broad-spectrum triazole antifungal agent used for the treatment of various fungal infections. Itraconazole works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. Xerofung 100 is indicated for the management of systemic and superficial mycoses, including aspergillosis, blastomycosis, histoplasmosis, onychomycosis, and candidiasis. It is particularly effective against dermatophytes, yeasts, and molds. The capsule formulation ensures optimal bioavailability and ease of administration. Dosage and duration of therapy should be tailored based on the type and severity of infection, patient response, and clinical judgment. Xerofung 100 should be taken with food to enhance absorption. Caution is advised in patients with hepatic impairment or congestive heart failure, and periodic monitoring of liver function tests is recommended during prolonged therapy. Potential drug interactions include those with agents metabolized by cytochrome P450 enzymes. Common adverse effects may include gastrointestinal disturbances, headache, and rash. Xerofung 100 Capsule should be used under medical supervision to ensure safety and efficacy in the treatment of fungal infections.